GREGORY A GOULD Insider Trading $AYTU AYTU BIOPHARMA, INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY A GOULD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY A GOULD. GREGORY A GOULD is Chief Financial Officer in ATRIX LABORATORIES INC ($ATRX) and Director in CytoDyn Inc. ($CYDY) and Chief Financial Officer in AYTU BIOSCIENCE, INC ($RSWN) and Chief Financial Officer in Ampio Pharmaceuticals, Inc. ($AMPE) and CFO in New Age Beverages Corp ($NBEV) and Chief Financial Officer in New Age Beverages Corp ($NBEV).
GREGORY A GOULD in AYTU BIOPHARMA, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY A GOULD: Chief Financial Officer
Holdings: 340,231 shares
Current Value: $302,806
Latest Transaction: Mar 17 2017
$AYTU Market Capitalization: $11.06M
$AYTU Previous Close: $0.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GREGORY A GOULD in AYTU BIOPHARMA, INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMPE, ATRX, AYTU, CYDY, NBEV
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2017 | AYTU | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 0.82 | 25,000 | 20,500 | 25,000 | |
| Mar 17 2017 | AYTU | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 0.82 | 20,834 | 17,084 | 20,834 | |
| Mar 17 2017 | AYTU | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | D | 3.23 | 25,000 | 80,750 | 0 | |
| Mar 17 2017 | AYTU | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | D | 3.23 | 20,834 | 67,294 | 0 | |
| Mar 01 2017 | AYTU | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | M | 1.86 | 66,666 | 123,999 | 0 | |
| Mar 01 2017 | AYTU | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Buy | M | 0.75 | 66,666 | 50,000 | 340,231 | 273.6 K to 340.2 K (+24.37 %) |
| Nov 04 2016 | AYTU | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | P | 1.86 | 66,666 | 123,999 | 66,666 | |
| Nov 04 2016 | AYTU | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Buy | P | 1.50 | 66,666 | 99,999 | 273,565 | 206.9 K to 273.6 K (+32.22 %) |
| Aug 04 2016 | RSWN | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Grant | A | 0.00 | 41,899 | 0 | 206,899 | 165 K to 206.9 K (+25.39 %) |
| Jul 11 2016 | RSWN | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 3.23 | 25,000 | 80,750 | 25,000 | |
| Jul 11 2016 | RSWN | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 3.23 | 20,834 | 67,294 | 20,834 | |
| Jul 11 2016 | RSWN | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | D | 18.12 | 20,834 | 377,512 | 0 | |
| Jul 11 2016 | RSWN | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Grant | A | 0.00 | 165,000 | 0 | 165,000 | 0 to 165 K |
| Nov 13 2015 | RSWN | AYTU BIOSCIENCE, I ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 1.51 | 250,000 | 377,500 | 250,000 |
Page: 1